Search research articles
Contact Us
Filters
Showing results (111-120 of 148) with videos related to
Page
of 15
Sort By:
European Journal of Immunology
|
January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Ivan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Plos One
|
December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes
Carlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
Acta Neuropathologica Communications
|
May 3, 2023
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease
Heather H C Lau, Ivan Martinez-Valbuena, Raphaella W L So, et al.
Translational Neurodegeneration
|
February 7, 2022
Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy
Ivan Martinez-Valbuena, Naomi P Visanji, Ain Kim, et al.
Molecular Cancer
|
October 21, 2024
MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2
Simone Anfossi, Faezeh Darbaniyan, Joseph Quinlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Aizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
Targeted Oncology
|
April 2, 2016
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial
Oscar Arrieta, Graciela Cruz-Rico, Enrique Soto-Perez-de-Celis, et al.
International Journal of Cancer
|
September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
Natalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Cancer Immunology, Immunotherapy : CII
|
March 26, 2010
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
Juan Dubrot, Francisca Milheiro, Carlos Alfaro, et al.
Human Immunology
|
January 20, 2026
A novel pathogenic RFXANK variant causing MHC class II deficiency in two unrelated patients from Mexico
Maria Enriqueta Nuñez-Nuñez, Lucero Valenzuela-Vazquez, Juan Carlos Bustamante-Ogando, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 148) with videos related to
Sort By:
Page
of 15
European Journal of Immunology
|
January 18, 2008
IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
Ivan Martinez-Forero, Ricardo Garcia-Munoz, Sara Martinez-Pasamar, et al.
Plos One
|
December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes
Carlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
Acta Neuropathologica Communications
|
May 3, 2023
The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease
Heather H C Lau, Ivan Martinez-Valbuena, Raphaella W L So, et al.
Translational Neurodegeneration
|
February 7, 2022
Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy
Ivan Martinez-Valbuena, Naomi P Visanji, Ain Kim, et al.
Molecular Cancer
|
October 21, 2024
MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2
Simone Anfossi, Faezeh Darbaniyan, Joseph Quinlan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Aizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
Targeted Oncology
|
April 2, 2016
Reduction in Hepatocyte Growth Factor Serum Levels is Associated with Improved Prognosis in Advanced Lung Adenocarcinoma Patients Treated with Afatinib: a Phase II Trial
Oscar Arrieta, Graciela Cruz-Rico, Enrique Soto-Perez-de-Celis, et al.
International Journal of Cancer
|
September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
Natalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Cancer Immunology, Immunotherapy : CII
|
March 26, 2010
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
Juan Dubrot, Francisca Milheiro, Carlos Alfaro, et al.
Human Immunology
|
January 20, 2026
A novel pathogenic RFXANK variant causing MHC class II deficiency in two unrelated patients from Mexico
Maria Enriqueta Nuñez-Nuñez, Lucero Valenzuela-Vazquez, Juan Carlos Bustamante-Ogando, et al.
Page
of 15